Generic versions of Advair Diskus dry powder inhaler now available in CanadaIndicated for use in the maintenance treatment of asthma and chronic obstructive pulmonary disease Early exposure to household cleaning products is associated with asthma and wheeze in young childrenThe researchers hypothesize that chemicals in cleaning products may damage the respiratory lining by triggering inflammatory pathways of the immune system British Columbia soon to implement new restrictions for some codeine-containing liquid preparations Will require a Controlled Prescription Program duplicate prescription form and storage in a time-delay safe Are the 2019 GINA asthma strategy recommendations applicable to Canada? Canadian Thoracic Society poses questions to Chair of GINA Scientific Committee Updated Canadian Thoracic Society guideline on pharmacotherapy for COPD Provides guidance and recommendations to optimize pharmacologic therapy for patients with stable chronic obstructive pulmonary disease A million Canadians may not know they have COPD, report states Updated guidelines for diagnosis and treatment of community-acquired pneumonia Highlight 16 key issues to help clinicians optimize therapy for their patients with CAP Symbicort Turbuhaler now approved for “prn” use as “anti-inflammatory reliever therapy” in mild persistent asthma Indicated for 'as needed' use to relieve asthma symptoms when they occur in patients with mild persistent asthma How smoking cessation in heavy smokers affects future cardiovascular risk Study examines time course of cardiovascular disease risk reduction after smoking cessation Key change in managing mild asthma recommended in 2019 GINA guidelines Short-acting bronchodilators used alone “as needed” are no longer recommended for adults or adolescents First Previous 31 32 33 34 35 Next Last
